Menu
US
Shop
Request a Quote
Contact Us
US
Case Study

High-content analysis of drug-induced oligodendrocyte differentiation promoting remyelination in multiple sclerosis

1175007_GettyImages-1359393159_1920x1080

One of the greatest challenges in multiple sclerosis (MS) therapy is the halting or reversal of the failure of remyelination in the brain in order to reverse disabilities in MS patients. This case study highlights the recent work of Dr. Paul Tesar and colleagues at the Case Western Reserve University School of Medicine, which could potentially lead to such novel treatments, as it aims to control the function of stem cells in the body and thereby to help the body repair itself.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

High-content analysis of drug-induced oligodendrocyte differentiation promoting remyelination in multiple sclerosis

Download Case Study